Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCAM spironolactone pragmatic trial in hypertension with glucose metabolism disorders
ChiCTR2000028909Phase 4Not yet recruiting
- Sponsor
- Hypertension Center of People's Hospital of Xinjiang Autonomous Region
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of spironolactone in hypertension (HTN) and carbohydrate malabsorption, sponsored by Hypertension Center of People's Hospital of Xinjiang Autonomous Region. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
spironolactone
03
Conditions
hypertension (HTN)carbohydrate malabsorption
Beyond the preview
Go deeper on ChiCTR2000028909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028909.